Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis - Top-Institutions - MDSpire

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Cornell University
    Cornell University

    Ithaca, New York

    Key Differentiators

    • Oncology

  • #2

    Chinese PLA General Hospital
    Chinese PLA General Hospital

    Beijing, Beijing

    Key Differentiators

    • Oncology

  • #3

    Chinese Genome Glioma Atlas (CGGA)
    Chinese Genome Glioma Atlas (CGGA)

    Nanjing, Jiangsu

    Key Differentiators

    • Oncology

  • #4

    Cancer Genome Atlas (TCGA)
    Cancer Genome Atlas (TCGA)

    Bethesda, Maryland

    Key Differentiators

    • Oncology

Original Source(s)

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026

Related Content

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study

Bilateral renal metastasis following radical prostatectomy for prostate cancer: a case report

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma